AMGEN INC (AMGN) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amgen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Amgen Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $991 M, a 48.4% decline year-over-year.
  • Amgen Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $6.97 B, a 22.5% decline year-over-year.
  • Amgen Inc annual Operating Income (Loss) for 2023 was $7.9 B, a 17.4% decline from 2022.
  • Amgen Inc annual Operating Income (Loss) for 2022 was $9.57 B, a 25.2% increase from 2021.
  • Amgen Inc annual Operating Income (Loss) for 2021 was $7.64 B, a 16.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.97 B $991 M -$930 M -48.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $7.9 B $1.27 B -$959 M -43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $8.86 B $2.02 B -$639 M -24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $9.5 B $2.68 B +$508 M +23.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $8.99 B $1.92 B -$579 M -23.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $9.57 B $2.23 B -$74 M -3.21% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $9.64 B $2.66 B +$282 M +11.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $9.36 B $2.18 B +$1.35 B +163% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $8.01 B $2.5 B +$371 M +17.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $7.64 B $2.3 B +$296 M +14.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $7.34 B $2.38 B -$75 M -3.06% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $7.42 B $828 M -$1.5 B -64.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $8.91 B $2.13 B -$226 M -9.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $9.14 B $2.01 B -$40 M -1.95% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $9.18 B $2.45 B -$23 M -0.93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $9.2 B $2.32 B -$355 M -13.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $9.56 B $2.36 B -$117 M -4.73% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $9.67 B $2.05 B -$334 M -14% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $10 B $2.48 B +$153 M +6.59% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $9.86 B $2.68 B -$154 M -5.44% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $10 B $2.47 B -$254 M -9.32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $10.3 B $2.38 B +$137 M +6.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $10.1 B $2.32 B -$116 M -4.76% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $10.2 B $2.83 B +$134 M +4.97% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $10.1 B $2.73 B +$135 M +5.21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $9.97 B $2.25 B -$240 M -9.66% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $10.2 B $2.44 B -$88 M -3.48% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $10.3 B $2.7 B +$318 M +13.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $9.98 B $2.59 B +$189 M +7.87% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $9.79 B $2.49 B +$452 M +22.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $9.34 B $2.53 B +$188 M +8.04% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $9.15 B $2.38 B +$304 M +14.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $8.85 B $2.4 B +$380 M +18.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $8.47 B $2.03 B +$574 M +39.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $7.9 B $2.34 B +$873 M +59.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $7.02 B $2.08 B +$174 M +9.15% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $6.85 B $2.02 B +$658 M +48.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $6.19 B $1.46 B +$272 M +22.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $5.92 B $1.47 B -$222 M -13.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $6.14 B $1.9 B +$352 M +22.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $5.79 B $1.36 B -$78 M -5.41% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $5.87 B $1.19 B +$99 M +9.1% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $5.77 B $1.69 B +$265 M +18.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $5.5 B $1.55 B -$39 M -2.45% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $5.54 B $1.44 B -$35 M -2.37% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $5.58 B $1.09 B -$74 M -6.37% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $5.65 B $1.42 B +$898 M +171% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $4.75 B $1.59 B +$257 M +19.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $4.5 B $1.48 B +$184 M +14.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $4.31 B $1.16 B +$94 M +8.8% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $4.22 B $525 M -$954 M -64.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $5.17 B $1.33 B -$185 M -12.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $5.36 B $1.29 B -$188 M -12.7% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $5.55 B $1.07 B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $1.48 B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.52 B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $1.48 B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.